The Prognostic Value of Soluble ST2 in Adults with Pulmonary Hypertension
Soluble ST2 (sST2) is upregulated in response to myocardial stress and may serve as biomarker in adults with pulmonary hypertension (PH). This prospective cohort study investigated sST2 levels and its association with echocardiographic and hemodynamic measures, and adverse clinical outcomes in adult...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-09-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/8/10/1517 |
id |
doaj-2acaa20d39ea4b46b6cabce98a4e63d1 |
---|---|
record_format |
Article |
spelling |
doaj-2acaa20d39ea4b46b6cabce98a4e63d12020-11-24T22:14:35ZengMDPI AGJournal of Clinical Medicine2077-03832019-09-01810151710.3390/jcm8101517jcm8101517The Prognostic Value of Soluble ST2 in Adults with Pulmonary HypertensionLaurie W. Geenen0Vivan J. M. Baggen1Robert M. Kauling2Thomas Koudstaal3Karin A. Boomars4Eric Boersma5Jolien W. Roos-Hesselink6Annemien E. van den Bosch7Department of Cardiology, Erasmus University Medical Center, 3015 GD Rotterdam, The NetherlandsDepartment of Cardiology, Erasmus University Medical Center, 3015 GD Rotterdam, The NetherlandsDepartment of Cardiology, Erasmus University Medical Center, 3015 GD Rotterdam, The NetherlandsDepartment of Pulmonary Medicine, Erasmus University Medical Center, 3015 GD Rotterdam, The NetherlandsDepartment of Pulmonary Medicine, Erasmus University Medical Center, 3015 GD Rotterdam, The NetherlandsDepartment of Cardiology, Erasmus University Medical Center, 3015 GD Rotterdam, The NetherlandsDepartment of Cardiology, Erasmus University Medical Center, 3015 GD Rotterdam, The NetherlandsDepartment of Cardiology, Erasmus University Medical Center, 3015 GD Rotterdam, The NetherlandsSoluble ST2 (sST2) is upregulated in response to myocardial stress and may serve as biomarker in adults with pulmonary hypertension (PH). This prospective cohort study investigated sST2 levels and its association with echocardiographic and hemodynamic measures, and adverse clinical outcomes in adults with PH of different etiologies. sST2 was measured during the diagnostic right heart catheterization for PH, in adult patients enrolled between May 2012 and October 2016. PH due to left heart failure was excluded. The association between sST2 and a primary endpoint composed of death or lung transplantation and a secondary composite endpoint including death, lung transplantation or heart failure, was investigated using Cox regression with adjustment for NT-proBNP. In total 104 patients were included (median age was 59 years, 66% woman, 51% pulmonary arterial hypertension). Median sST2 was 28 [IQR 20−46] ng/mL. Higher sST2 was associated with worse right ventricular dysfunction and higher mean pulmonary and right atrial pressures. Median follow-up was 3.3 [IQR 2.3−4.6] years. The primary and secondary endpoint occurred in 33 (31.7%) and 43 (41.3%) patients, respectively. sST2 was significantly associated with both endpoints (HR per 2-fold higher value 1.53, 95%CI 1.12−2.07, <i>p</i> = 0.007 and 1.45, 95%CI 1.10−1.90, <i>p</i> = 0.008, respectively). However, after adjustment for NT-proBNP, both associations did not reach statistical significance. In conclusions, higher sST2 levels are associated with more severe PH and right ventricular dysfunction and yields prognostic value in adults with PH, although not independently of NT-proBNP.https://www.mdpi.com/2077-0383/8/10/1517ST2pulmonary hypertensionbiomarkers |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Laurie W. Geenen Vivan J. M. Baggen Robert M. Kauling Thomas Koudstaal Karin A. Boomars Eric Boersma Jolien W. Roos-Hesselink Annemien E. van den Bosch |
spellingShingle |
Laurie W. Geenen Vivan J. M. Baggen Robert M. Kauling Thomas Koudstaal Karin A. Boomars Eric Boersma Jolien W. Roos-Hesselink Annemien E. van den Bosch The Prognostic Value of Soluble ST2 in Adults with Pulmonary Hypertension Journal of Clinical Medicine ST2 pulmonary hypertension biomarkers |
author_facet |
Laurie W. Geenen Vivan J. M. Baggen Robert M. Kauling Thomas Koudstaal Karin A. Boomars Eric Boersma Jolien W. Roos-Hesselink Annemien E. van den Bosch |
author_sort |
Laurie W. Geenen |
title |
The Prognostic Value of Soluble ST2 in Adults with Pulmonary Hypertension |
title_short |
The Prognostic Value of Soluble ST2 in Adults with Pulmonary Hypertension |
title_full |
The Prognostic Value of Soluble ST2 in Adults with Pulmonary Hypertension |
title_fullStr |
The Prognostic Value of Soluble ST2 in Adults with Pulmonary Hypertension |
title_full_unstemmed |
The Prognostic Value of Soluble ST2 in Adults with Pulmonary Hypertension |
title_sort |
prognostic value of soluble st2 in adults with pulmonary hypertension |
publisher |
MDPI AG |
series |
Journal of Clinical Medicine |
issn |
2077-0383 |
publishDate |
2019-09-01 |
description |
Soluble ST2 (sST2) is upregulated in response to myocardial stress and may serve as biomarker in adults with pulmonary hypertension (PH). This prospective cohort study investigated sST2 levels and its association with echocardiographic and hemodynamic measures, and adverse clinical outcomes in adults with PH of different etiologies. sST2 was measured during the diagnostic right heart catheterization for PH, in adult patients enrolled between May 2012 and October 2016. PH due to left heart failure was excluded. The association between sST2 and a primary endpoint composed of death or lung transplantation and a secondary composite endpoint including death, lung transplantation or heart failure, was investigated using Cox regression with adjustment for NT-proBNP. In total 104 patients were included (median age was 59 years, 66% woman, 51% pulmonary arterial hypertension). Median sST2 was 28 [IQR 20−46] ng/mL. Higher sST2 was associated with worse right ventricular dysfunction and higher mean pulmonary and right atrial pressures. Median follow-up was 3.3 [IQR 2.3−4.6] years. The primary and secondary endpoint occurred in 33 (31.7%) and 43 (41.3%) patients, respectively. sST2 was significantly associated with both endpoints (HR per 2-fold higher value 1.53, 95%CI 1.12−2.07, <i>p</i> = 0.007 and 1.45, 95%CI 1.10−1.90, <i>p</i> = 0.008, respectively). However, after adjustment for NT-proBNP, both associations did not reach statistical significance. In conclusions, higher sST2 levels are associated with more severe PH and right ventricular dysfunction and yields prognostic value in adults with PH, although not independently of NT-proBNP. |
topic |
ST2 pulmonary hypertension biomarkers |
url |
https://www.mdpi.com/2077-0383/8/10/1517 |
work_keys_str_mv |
AT lauriewgeenen theprognosticvalueofsolublest2inadultswithpulmonaryhypertension AT vivanjmbaggen theprognosticvalueofsolublest2inadultswithpulmonaryhypertension AT robertmkauling theprognosticvalueofsolublest2inadultswithpulmonaryhypertension AT thomaskoudstaal theprognosticvalueofsolublest2inadultswithpulmonaryhypertension AT karinaboomars theprognosticvalueofsolublest2inadultswithpulmonaryhypertension AT ericboersma theprognosticvalueofsolublest2inadultswithpulmonaryhypertension AT jolienwrooshesselink theprognosticvalueofsolublest2inadultswithpulmonaryhypertension AT annemienevandenbosch theprognosticvalueofsolublest2inadultswithpulmonaryhypertension AT lauriewgeenen prognosticvalueofsolublest2inadultswithpulmonaryhypertension AT vivanjmbaggen prognosticvalueofsolublest2inadultswithpulmonaryhypertension AT robertmkauling prognosticvalueofsolublest2inadultswithpulmonaryhypertension AT thomaskoudstaal prognosticvalueofsolublest2inadultswithpulmonaryhypertension AT karinaboomars prognosticvalueofsolublest2inadultswithpulmonaryhypertension AT ericboersma prognosticvalueofsolublest2inadultswithpulmonaryhypertension AT jolienwrooshesselink prognosticvalueofsolublest2inadultswithpulmonaryhypertension AT annemienevandenbosch prognosticvalueofsolublest2inadultswithpulmonaryhypertension |
_version_ |
1725798159511191552 |